Clinical Trials

50 enrolled

Advanced Squamous Non-Small Cell Lung Carcinoma

NCT02786589 2023-06-22

Plasmodium Immunotherapy for Lung Cancer

Carcinoma, Non-Small-Cell Lung, Malaria, Vivax

NCT04631731 2023-06-01

ICEMELT

DermatologicGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

200 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Stomach Neoplasms, Endometrial Neoplasms

NCT05498389 2023-06-01

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

115 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03797391 2023-05-31

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

186 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT05859373 2023-05-16

To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.

78 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04348643 2023-04-18

Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

BreastGastrointestinalThoracic

40 enrolled

Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05278364 2023-04-12

Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor

184 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Medullary

NCT05641493 2023-04-10

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation

49 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05805956 2023-04-10

IMM2902 in Patients With Advanced Solid Tumors Expressing HER2

GastrointestinalOther solid neoplasmThoracic

105 enrolled

Advanced Solid Tumor

NCT04646837 2023-03-29

Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03475953 2023-03-03

REGOMUNE

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

747 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05257512 2023-02-14

Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05715398 2023-02-10

BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung Cancer

90 enrolled

Carcinoma, Non-Small-Cell Lung, Noonan Syndrome

NCT02981108 2023-01-23

A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC

364 enrolled 29 charts

Carcinoma, Non-Small-Cell Lung

NCT04996771 2022-11-14

Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer

88 enrolled

Small Cell Lung Carcinoma

NCT00100256 2022-11-07

Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Recurrence, Local, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT05588206 2022-10-20

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

21 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05505877 2022-08-18

Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors

160 enrolled

Head & NeckThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung

NCT05332574 2022-08-05

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Other solid neoplasmThoracic

120 enrolled

NSCLC

NCT05068024 2022-07-26

FWD1509

Carcinoma, Non-Small-Cell Lung

NCT05468294 2022-07-21

Nivokin

3 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05265650 2022-07-19

Noelia

Non-Small Cell Lung Cancer Metastatic

NCT05435274 2022-06-28

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

380 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02562963 2022-05-02

Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor

120 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms

NCT05329298 2022-04-15

A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05330065 2022-04-15

A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion

55 enrolled

Pleural Effusion, Malignant

NCT05236608 2022-03-25

ADIVO Lung

53 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05284994 2022-03-17

TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer

160 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05267392 2022-03-04

IDEAR

Carcinoma, Non-Small-Cell Lung

NCT02446704 2022-02-07

Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy

66 enrolled

Small Cell Lung Carcinoma

NCT05158491 2022-01-05

Safety, Tolerability and Preliminary Efficacy of JK1201I in Patients With SCLC

63 enrolled

Small Cell Lung Carcinoma

NCT05117138 2021-11-11

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors

DermatologicHead & NeckThoracic

39 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT05079022 2021-10-15

ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas

50 enrolled

Adenocarcinoma of Lung, Neoplasm, Residual

NCT02330367 2021-09-10

Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC

368 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04521075 2021-08-16

A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC